The present invention relates to fusion proteins of antigens. In particular, it relates to two fusion proteins, each of which contains three individual antigens, and a fusion protein of two antigens, their coding sequences, and methods for their use in the treatment and prevention of tuberculosis.
Leishmania Antigens For Use In The Therapy And Diagnosis Of Leishmaniasis
Steven G. Reed - Bellevue WA Antonio Campos-Neto - Bainbridge Island WA John R. Webb - Manotick, CA Davin C. Dillon - Issaquah WA Yasir A. Skeiky - Bellevue WA Ajay Bhatia - Seattle WA Rhea Coler - Seattle WA Peter Probst - Seattle WA
Compositions and methods for preventing, treating and detecting leishmaniasis and stimulating immune responses in patients are disclosed. The compounds provided include polypeptides that contain at least an immunogenic portion of one or more Leishmania antigens, or a variant thereof. Vaccines and pharmaceutical compositions comprising such polypeptides, or polynucleotides encoding such polypeptides, are also provided and may be used, for example, for the prevention and therapy of leishmaniasis, as well as for the detection of Leishmania infection.
Fusion Proteins Of Mycobacterium Tuberculosis Antigens And Their Uses
Steven G. Reed - Bellevue WA Yasir A. Skeiky - Seattle WA Davin C. Dillon - Redmond WA Mark Alderson - Bainbridge Island WA Antonio Campos-Neto - Bainbridge Island WA
The present invention relates to fusion proteins containing at least two antigens. In particular, it relates to bi-fusion proteins which contain two individual antigens, tri-fusion proteins which contain three antigens, tetra-fusion proteins which contain four antigens, and penta-fusion proteins which contain five antigens, and methods for their use in the diagnosis, treatment and prevention of tuberculosis infection.
Fusion Proteins Of Mycobacterium Tuberculosis Antigens And Their Uses
Steven G. Reed - Bellevue WA, US Yasir A. Skeiky - Bellevue WA, US Davin C. Dillon - Redmond WA, US Mark Alderson - Bainbridge WA, US Antonio Campos-Neto - Bainbridge Island WA, US
The present invention relates to fusion proteins containing at least two antigens. In particular, it relates to bi-fusion proteins which contain two individual antigens, tri-fusion proteins which contain three antigens, tetra-fusion proteins which contain four antigens, and penta-fusion proteins which contain five antigens, and methods for their use in the diagnosis, treatment and prevention of tuberculosis infection.
Methods Of Using A Coding Sequence To Facilitate Stable And High Yield Expression Of The Heterologous Proteins
Yasir Skeiky - Seattle WA, US Jeffrey Guderian - Lynnwood WA, US
Assignee:
Corixa Corporation - Seattle WA
International Classification:
C07H 21/04 A61K 38/00
US Classification:
536 231, 435 691, 435455, 4353201, 514 2
Abstract:
The present invention relates generally to nucleic acid and amino acid sequences of a fusion polypeptide comprising a polypeptide, and a heterologous polypeptide of interest, expression vectors and host cells comprising such nucleic acids, and methods for producing such fusion polypeptides. In particular, the invention relates to materials and methods of using such sequence as a fusion partner to facilitate the stable and high yield expression of recombinant heterologous polypeptides of both eukaryotic and prokaryotic origin.
The present invention relates to compositions and fusion proteins containing at least two sp. antigens, and nucleic acids encoding such compositions and fusion proteins. The compositions of the invention increase serological sensitivity of sera from individuals infected with tuberculosis, and methods for their use in the diagnosis, treatment, and prevention of tuberculosis infection.
Fusion Proteins Of Mycobacterium Tuberculosis Antigens And Their Uses
The present invention relates to fusion proteins of antigens. In particular, it relates to two fusion proteins, each of which contains three individual antigens, and a fusion protein of two antigens, their coding sequences, and methods for their use in the treatment and prevention of tuberculosis.
The present invention relates to compositions and fusion proteins containing at least two sp. antigens, and nucleic acids encoding such compositions and fusion proteins. The compositions of the invention increase serological sensitivity of sera from individuals infected with tuberculosis, and methods for their use in the diagnosis, treatment, and prevention of tuberculosis infection.